Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL2163079

FC(F)(F)Oc1ccccc1.N

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 3/20 0.46
GRIN2B Q13224 1/20 0.44
MAPT P10636 3/20 0.43
EPHX2 P34913 2/20 0.43
LTA4H P09960 2/20 0.43
TSHR P16473 1/20 0.43
GPR3 P46089 1/20 0.42
SLC7A5 Q01650 2/20 0.42
CCR6 P51684 2/20 0.42
KCNH2 Q12809 2/20 0.42
PLA2G1B P04054 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
ATG4B Q9Y4P1 1/20 0.42
SLC6A4 P31645 2/20 0.42
SLC6A2 P23975 1/20 0.42
SLC6A3 Q01959 1/20 0.42
MEN1 O00255 1/20 0.42
HTT P42858 1/20 0.42
RAB9A P51151 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL168125 0.97 KIF11 (0.47) KIF11GRIN2BMAPTEPHX2LTA4H
SCHEMBL27862141 0.97 KIF11 (0.47) KIF11GRIN2BMAPTEPHX2LTA4H
SCHEMBL4036806 0.94 KIF11 (0.46) KIF11GRIN2BMAPTEPHX2LTA4H
SCHEMBL29087324 0.94 KIF11 (0.46) KIF11GRIN2BMAPTEPHX2LTA4H
Hydrogen Sulfide SCHEMBL27539287 0.94 KIF11 (0.46) KIF11GRIN2BMAPTEPHX2LTA4H
SCHEMBL4036809 0.94 KIF11 (0.46) KIF11GRIN2BMAPTEPHX2LTA4H
Fluoride SCHEMBL28371495 0.94 KIF11 (0.46) KIF11GRIN2BMAPTEPHX2LTA4H
Water SCHEMBL27610464 0.94 KIF11 (0.46) KIF11GRIN2BMAPTEPHX2LTA4H
Nitrogen SCHEMBL29122681 0.92 KIF11 (0.44) KIF11GRIN2BMAPTEPHX2LTA4H
Ethyne SCHEMBL28472442 0.92 KIF11 (0.44) KIF11GRIN2BMAPTEPHX2LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8349835-B2 Aromatic ring fused triazine derivatives and uses thereof SHENYANG PHARMACEUTICAL UNIVERSITY (CN) 2013-01-08 US disclosed
US-20110183972-A1 AROMATIC RING FUSED TRIAZINE DERIVATIVES AND USES THEREOF SHENYANG PHARMACEUTICAL UNIVERSITY (CN) 2011-07-28 US disclosed
EP-2251332-A1 THE AROMATIC RING TRIAZINE DERIVATIVES AND THE USES THEREOF Shenyang Pharmaceutical University (CN) 2010-11-17 EP disclosed
CN-100497345-C 2, 3-dihydro-6-nitroimidazolo [2,1-b] oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2009-06-10 CN disclosed
CN-1878777-A 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2006-12-13 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110183972-A1 AROMATIC RING FUSED TRIAZINE DERIVATIVES AND USES THEREOF KDR, FLT1, FLT4 KIF11 935/4885GRIN2B 4275/4885MAPT 1553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.